A randomized trial of aspirin to prevent colorectal adenomas
…, N Marcon, LA Mott, L Pearson, F Saibil… - Obstetrical & …, 2003 - journals.lww.com
John A. Baron, Bernard F. Cole, Robert S. Sandler, Robert W. Haile, Dennis Ahnen, Robert
Bresalier, Gail McKeown-Eyssen, Robert W. Summers, Richard Rothstein, Carol A. Burke, …
Bresalier, Gail McKeown-Eyssen, Robert W. Summers, Richard Rothstein, Carol A. Burke, …
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial
…, LH Pearson, EL Barry, JR Rees, N Marcon, F Saibil… - Jama, 2007 - jamanetwork.com
ContextLaboratory and epidemiological data suggest that folic acid may have an antineoplastic
effect in the large intestine.ObjectiveTo assess the safety and efficacy of folic acid …
effect in the large intestine.ObjectiveTo assess the safety and efficacy of folic acid …
5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis
…, S Greer, M Robinson, N Greenberger, F Saibil… - Gastroenterology, 1987 - Elsevier
The efficacy and safety of 4-g 5-aminosalicylic acid enemas were assessed in 153 patients
with ulcerative colitis involving up to 50 cm of distal colon. Seventy-six patients received …
with ulcerative colitis involving up to 50 cm of distal colon. Seventy-six patients received …
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease
…, A Cohen, RN Fedorak, P Paré, A Bitton, F Saibil… - Gastroenterology, 2014 - Elsevier
Background & Aims Methotrexate and infliximab are effective therapies for Crohn's disease (CD).
In the combination of maintenance methotrexate-infliximab trial, we evaluated the …
In the combination of maintenance methotrexate-infliximab trial, we evaluated the …
[HTML][HTML] Inflammatory bowel disease and thromboembolism
P Zezos, G Kouklakis, F Saibil - World journal of gastroenterology …, 2014 - ncbi.nlm.nih.gov
Patients with inflammatory bowel disease (IBD) have an increased risk of vascular complications.
Thromboembolic complications, both venous and arterial, are serious extraintestinal …
Thromboembolic complications, both venous and arterial, are serious extraintestinal …
[HTML][HTML] Low-dose cyclosporine for the treatment of Crohn's disease
…, RN Fedorak, D Kinnear, F Saibil… - … England Journal of …, 1994 - Mass Medical Soc
Background Long-term corticosteroid therapy for Crohn's disease is associated with important
types of morbidity, such as osteoporosis. Safe and effective alternative treatments are …
types of morbidity, such as osteoporosis. Safe and effective alternative treatments are …
[HTML][HTML] Inflammatory pouch disease: the spectrum of pouchitis
P Zezos, F Saibil - World Journal of Gastroenterology: WJG, 2015 - ncbi.nlm.nih.gov
Restorative proctocolectomy with ileal-pouch anal anastomosis (IPAA) is the operation of
choice for medically refractory ulcerative colitis (UC), for UC with dysplasia, and for familial …
choice for medically refractory ulcerative colitis (UC), for UC with dysplasia, and for familial …
The impact of magnetic resonance enterography and capsule endoscopy on the re-classification of disease in patients with known Crohn's disease: a prospective …
…, I Dotan, Y Chowers, B Weiss, F Saibil… - Journal of Crohn's …, 2016 - academic.oup.com
Background and aims: The classification of Crohn’s disease (CD) is usually determined at
initial diagnosis and is frequently based on ileocolonoscopic and cross-sectional imaging data…
initial diagnosis and is frequently based on ileocolonoscopic and cross-sectional imaging data…
[PDF][PDF] A randomized trial of methotrexate in combination with infliximab for the treatment of Crohn's disease
…, A Cohen, R Fedorak, P Pare, A Bitton, F Saibil… - …, 2008 - academia.edu
Background: The SEDASYS System (SS) is an investigational, computerassisted, personalized
sedation system intended to provide endoscopist/nurse teams an “on-label” method to …
sedation system intended to provide endoscopist/nurse teams an “on-label” method to …
Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf
M Katz, F Saibil - Journal of clinical gastroenterology, 1990 - journals.lww.com
A 33-year-old woman developed subacute hepatic necrosis after several months of ingestion
of Chaparral Leaf, an herbal product. Symptoms first appeared 3 months after she began …
of Chaparral Leaf, an herbal product. Symptoms first appeared 3 months after she began …